Why is Decentralized Health So Much More Successful in Emerging Markets and Developing Economies? with Dr. Alex Cahana | Partner, Impact Rooms The episode elucidates the economic, regulatory and cultural reasons why decentralized health is so much more successful in EMDE (emerging markets and developing economies) when compared to the US and EU.
Future Strategies Utilizing DAO’s and NFT’s in a Heavily Regulated Environment Bart Cant | CTO, Tydei.io John Hatchell| Co-Founder and Chief Executive Officer, Tydei.io What elements of blockchain technology can healthcare benefit from TODAY without committing to decentralization The strategy for utilizing DAML for the purpose of progressive decentralization in enterprise Converging how TradFi was brought on chain to innovate healthcare payments
Building Comfort and Success at Failing Sarah B. Harper, MA, MBA | Operations Manager, Artificial Intelligence and Biomedical Informatics, and Instructor of Healthcare Administration, Mayo Clinic College of Medicine and Science, Mayo Clinic Rochester, USA Samuel West, PhD | Curator and Founder, The Museum of Failure, Helsingborg, Sweden Paul Barach, BS, MD | Thomas Jefferson University, USA; Imperial College London, UK; Principal at J. Bara Innovation, and Chief Medical Officer, Pegwin, USA Failing is an important issue for businesses. Embracing it moves markets, insures consumer safety, and spares unnecessary investment. Are the aviation and nuclear power industries the only industries to truly embrace it and share learnings to fortify standards and best practices? Can healthcare do the same?
Concerns About Equitable Access to Telehealth Services Katrin Zimmermann | Managing Director, TLGG, North America There are three types of known “telehealth players” and only two will prevail in the future. The first type are credible known entities like Cleveland Clinic, UnitedHealth Group, CVS Health, or Amazon Care, which would be their online arm. The second type will be telehealth solutions that broker availability of different services between brands. The third type – and the one that won’t work – is the standalone solution. From a patient standpoint, more credibility is needed to use these services. Smart market players in the telehealth industry anticipate future trends and make sure business focuses on several consumer problems, not one. Further, there are concerns about equitable access to telehealth services, particularly for video telehealth – something HCPs and telehealth companies should think about as telehealth becomes a long-term/permanent solution. Basic technological barriers like lack of broadband access, digital literacy, social isolation, disparities in technology/device ownership prevent patients from engaging with their providers via telehealth. These barriers have disproportionate impacts across different populations. Additionally, social data gaps – low technology for certain sub-populations indicates minimal data availability.
Translational AI Panel Discussion from ConV2X Sandeep Reddy, MBBS, MSc, PhD | Director, MBA (Healthcare Management), Deakin School of Medicine, and Chairman, Medi-AI Alexandre Lebrun | CEO, Nabla Adam Chee, PhD | Chief, Smart Health Leadership Centre, Institute of Systems Science National University of Singapore Moderator: Dimitris Kalogeropoulos, PhD | CEO, Global Health and Digital Innovation Foundation How do we evaluate large language models for use in healthcare? What are the trusted frameworks for value assessment? Is automation through GPT successfully addressing the healthcare administrative and workforce crisis? What about clinical decision making? Expect a candid discussion from these experts on the implications of LLM’s and AI in Primary Care in the US and around the globe.